Vistagen Therapeutics Inc. (VTGN)
VTGN trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.2148
-5.21% on the day
Market cap
$9.5M
Nano cap
Revenue · 2025
$1.3M
No prior year to compare
Net income · 2025
-$69.7M
-5491.9% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/1411685/000162828026043271/0001628280-26-043271-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2026-03-31.
Profile
| Field | Value |
|---|---|
| Ticker | VTGN on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001411685 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | NV |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.3M |
| Net income | -$69.7M |
| Operating income | -$72.1M |
| Net margin | -5491.9% |
| Operating margin | -5683.7% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $47.4M |
| Total assets | $65.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 7.5× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2025-06-17 |
| Latest annual report | 10-K | 2026-06-15 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report | 8-K | 2026-10-09 |
| Latest proxy | DEFA14A | 2026-07-31 |
Source: SEC EDGAR submissions feed, 907 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MTVA | MetaVia Inc. | $1.43 | -1.38% | $9.4M |
| KPTI | Karyopharm Therapeutics Inc. | $0.4274 | -15.38% | $9.7M |
| TOVX | Theriva Biologics Inc. | $0.2157 | -1.69% | $9.9M |
| CMMB | Chemomab Therapeutics Ltd. American Depositary Share | $1.24 | -10.79% | $9.0M |
| MBRX | Moleculin Biotech Inc. | $0.4352 | +5.15% | $8.9M |
| GDTC | CytoMed Therapeutics Limited | $0.8700 | +7.22% | $10.3M |
| BIVI | BioVie Inc. | $1.20 | -9.09% | $10.4M |
| ADIL | Adial Pharmaceuticals Inc | $3.29 | -6.00% | $8.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier